Given that formyl-kynurenine was significantly upregulated by ADT, it is highly likely that ADT may induce IDO1 and/or TDO2 expression in prostate cancer (IDO2 has been reported to be expressed mainly in immune cells32,33). Here, IDO2 is linked to prostate carcinoma.